Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Kei Ichijo, Keisuke Takahata, Shin Kurose, Takemi Watanabe, Yukihiro Nagase, Hironobu Endo, Kenji Tagai, Makoto Ishitobi, Makoto Higuchi
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867010799571042304
author Kei Ichijo
Keisuke Takahata
Shin Kurose
Takemi Watanabe
Yukihiro Nagase
Hironobu Endo
Kenji Tagai
Makoto Ishitobi
Makoto Higuchi
author_facet Kei Ichijo
Keisuke Takahata
Shin Kurose
Takemi Watanabe
Yukihiro Nagase
Hironobu Endo
Kenji Tagai
Makoto Ishitobi
Makoto Higuchi
Kei Ichijo
Keisuke Takahata
Shin Kurose
Takemi Watanabe
Yukihiro Nagase
Hironobu Endo
Kenji Tagai
Makoto Ishitobi
Makoto Higuchi
collection Wiley Open Access
contents Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series Kei Ichijo Keisuke Takahata Shin Kurose Takemi Watanabe Yukihiro Nagase Hironobu Endo Kenji Tagai Makoto Ishitobi Makoto Higuchi Psychiatry and Clinical Neurosciences Reports AbstractAimProgressive supranuclear palsy (PSP) is a rapidly progressive neurodegenerative disorder characterized by Parkinsonism, supranuclear ophthalmoplegia, postural instability, and cognitive impairment.PatientsThis case series describes three patients initially diagnosed with late‐life mood disorders (depression and bipolar disorder) who were later diagnosed with PSP because of the development of typical neurological symptoms.ResultThe diagnostic challenge of PSP is highlighted in this case report, particularly in the early stages, when characteristic symptoms may not be present. The importance of considering PSP in the differential diagnosis of late‐life mood disorders, especially in the absence of response to standard antidepressant therapy, is also emphasized. The heterogeneity of PSP is described, with various subtypes and atypical variants presenting with different clinical features. The psychiatric symptoms of PSP include apathy, disinhibition, depression, and anxiety, whereas hallucinations and delusions are less frequent. Tau positron emission tomography imaging is discussed as a potential biomarker for atypical PSP.ConclusionEarly diagnosis and intervention are crucial for improved outcomes in PSP, necessitating further research to enhance the diagnostic and treatment strategies for PSP and other neurodegenerative diseases. 10.1002/pcn5.178 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/pcn5.178
format Artículo Open Access
id wiley_oa_10_1002_pcn5_178
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series
Kei Ichijo
Keisuke Takahata
Shin Kurose
Takemi Watanabe
Yukihiro Nagase
Hironobu Endo
Kenji Tagai
Makoto Ishitobi
Makoto Higuchi
Psychiatry and Clinical Neurosciences Reports
Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series Kei Ichijo Keisuke Takahata Shin Kurose Takemi Watanabe Yukihiro Nagase Hironobu Endo Kenji Tagai Makoto Ishitobi Makoto Higuchi Psychiatry and Clinical Neurosciences Reports AbstractAimProgressive supranuclear palsy (PSP) is a rapidly progressive neurodegenerative disorder characterized by Parkinsonism, supranuclear ophthalmoplegia, postural instability, and cognitive impairment.PatientsThis case series describes three patients initially diagnosed with late‐life mood disorders (depression and bipolar disorder) who were later diagnosed with PSP because of the development of typical neurological symptoms.ResultThe diagnostic challenge of PSP is highlighted in this case report, particularly in the early stages, when characteristic symptoms may not be present. The importance of considering PSP in the differential diagnosis of late‐life mood disorders, especially in the absence of response to standard antidepressant therapy, is also emphasized. The heterogeneity of PSP is described, with various subtypes and atypical variants presenting with different clinical features. The psychiatric symptoms of PSP include apathy, disinhibition, depression, and anxiety, whereas hallucinations and delusions are less frequent. Tau positron emission tomography imaging is discussed as a potential biomarker for atypical PSP.ConclusionEarly diagnosis and intervention are crucial for improved outcomes in PSP, necessitating further research to enhance the diagnostic and treatment strategies for PSP and other neurodegenerative diseases. 10.1002/pcn5.178 http://creativecommons.org/licenses/by/4.0/
title Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series
topic Psychiatry and Clinical Neurosciences Reports
url https://onlinelibrary.wiley.com/doi/10.1002/pcn5.178